Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder

author
contributor
inLanguage
  • en
isPartOf
name
  • Inhalable antifibrotic compounds :
  • Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder
P60049

Instances

Inhalable antifibrotic compounds :

isbn
  • 9789515144201
isPartOf
name
  • Inhalable antifibrotic compounds :

Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder

description
  • Yhteenveto-osa julkaistu myös verkkoaineistona
isPartOf
name
  • Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder

Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder

bookFormat
isPartOf
name
  • Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder
url

Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder

datePublished
  • 2018
description
  • Artikkeliväitöskirjan yhteenveto-osa ja 3 eripainosta.
  • kuvitettu
isbn
  • 9789515144195
isPartOf
name
  • Inhalable antifibrotic compounds : development of a formulation method and formulation of antifibrotic small molecule tilorone as inhalable dry powder
numberOfPages
  • 80 sivua, 31 sivua useina numerointijaksoina
P60048
P60050
publication
  • location: Finland organizer: University of Helsinki, Faculty of Medicine
publisher
  • University of Helsinki, Faculty of Medicine

Download this resource as RDF: